India
Biocon Launches Interchangeable YESAFILI Biosimilar to EYLEA in the U.S.
Yesafili™ (aflibercept-jbvf) now available in the United States as an U.S. FDA-approved interchangeable biosimilar to EYLEA 2 mg Potential ...
August 06, 2026 | News
Enzene Launches NeX™ to Enable Local Biologics Manufacturing Worldwide
Enzene, a leading global continuously innovative development and manufacturing organization (CIDMO™), announced the launch of NeX™, a transform...
August 05, 2026 | News
7 Countries Competing to Be the Region’s Next Biomanufacturing Hub
A siting decision for a biomanufacturing facility is one of the most expensive commitments a company makes, and it is made against a fifteen to twenty year...
July 27, 2026 | Analysis
India Approves First Dengue Vaccine as Cases Surge 11-Fold Over Two Decades
The approval comes at a critical time for public health, as reported dengue cases in India have increased 11-fold in the past two decades[1] Takeda's de...
July 22, 2026 | News
Samsung Biologics Launches CHF 1.46B All-Cash Bid to Acquire PolyPeptide
Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding therefrom any treasury share...
July 21, 2026 | News
India’s Life Sciences Proposition Expands from Global Scale to Strategic Innovation
India’s position in the global life sciences economy has long been anchored in scale — from active pharmaceutical ingredients (APIs) and generi...
July 20, 2026 | News
India's Garware Fulflex Acquires U.S. Medical Manufacturing Facility to Accelerate Global Expansion
Garware Fulflex today announced the successful completion of its acquisition of a 300,000-square-foot, fully automated medical products manufacturing facil...
July 10, 2026 | News
APAC's Peptide-Capacity Gamble
For most of pharmaceutical history, the hard part was finding a molecule that worked. The GLP-1 class inverted that logic. The science arrived first &mdash...
July 09, 2026 | Analysis
The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
In Songdo and Bengaluru, the numbers finally look like the ones the region was promised a decade ago. Celltrion closed 2025 with revenue above ₩4 trillio...
July 07, 2026 | Analysis
Shantha Biologics Signs Fill-Finish Manufacturing Agreement with Novo Nordisk in India
Shantha Biologics announced that it has entered into an outsourcing agreement with Novo Nordisk to provide cartridge fill-finish manufacturing services&nbs...
July 02, 2026 | News
Milliken Strengthens India Innovation Hub with New Advanced Pilot Plant in Pune
Facility strengthens ability to accelerate development and scale advanced material solutions for global markets. Milliken & Company has ope...
June 25, 2026 | News
Avance Clinical Expands APAC And China Operations To Accelerate Global Biotech Trials
Avance Clinical, the Australian-headquartered global Contract Research Organization (CRO) for biotechs, announced a significant expansion of its Asia Pacif...
June 22, 2026 | News
Can the 'Pharmacy of the World' Survive Its Own Scandals?
In late September and early October 2025, children in the central Indian state of Madhya Pradesh began arriving at hospitals with the same grim trajectory:...
June 08, 2026 | Analysis
Lupin Limited Enters China Market With Approval For Paediatric Oseltamivir Oral Suspension
Global pharmaceutical company Lupin Limited announced that China's National Medical Products Administration has approved the shortened marketing authorizat...
May 25, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
